نتائج البحث

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

• Authors : May MT; Sterne JA ...

Subjects: HIV-1*; Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/*statistics & numerical data ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: Lancet (London, England) [Lancet] 2006 Aug 05; Vol. 368 (9534), pp. 451-8.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

• Authors : Porter K; Babiker A ...

Subjects: Antiretroviral Therapy, Highly Active*/Antiretroviral Therapy, Highly Active*/Antiretroviral Therapy, Highly Active*/statistics & numerical data; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Infections/HIV Infections/HIV Infections/*mortality

• Source: Lancet (London, England) [Lancet] 2003 Oct 18; Vol. 362 (9392), pp. 1267-74.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

• Authors : Egger M; May M ...

Subjects: Antiretroviral Therapy, Highly Active* ; HIV-1*; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: Lancet (London, England) [Lancet] 2002 Jul 13; Vol. 360 (9327), pp. 119-29.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe.

Subjects: HIV-1*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: Lancet (London, England) [Lancet] 2000 Apr 01; Vol. 355 (9210), pp. 1158-9.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.

Subjects: Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*mortality ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Seropositivity/HIV Seropositivity/HIV Seropositivity/*mortality

• Source: Lancet (London, England) [Lancet] 2000 Apr 01; Vol. 355 (9210), pp. 1131-7.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

تفاصيل العنوان